Lecanemab
98%, 100mg/mL in PBS
- Product Code: 128216
CAS:
1260393-98-3
Properties:
This product is sold at the weight of dry products
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in the treatment of early-stage Alzheimer’s disease, lecanemab targets amyloid-beta plaques in the brain, helping to slow cognitive decline. It is administered intravenously and has shown efficacy in reducing disease progression in clinical trials involving patients with mild cognitive impairment or mild dementia due to Alzheimer’s. The drug supports disease modification by clearing amyloid aggregates, a hallmark of the condition, and is intended for use alongside diagnostic tools that confirm the presence of amyloid pathology.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1mg | 10-20 days | ฿33,190.00 |
+
-
|
Lecanemab
Used in the treatment of early-stage Alzheimer’s disease, lecanemab targets amyloid-beta plaques in the brain, helping to slow cognitive decline. It is administered intravenously and has shown efficacy in reducing disease progression in clinical trials involving patients with mild cognitive impairment or mild dementia due to Alzheimer’s. The drug supports disease modification by clearing amyloid aggregates, a hallmark of the condition, and is intended for use alongside diagnostic tools that confirm the presence of amyloid pathology.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :